Respiratory Tract Diseases clinical trials

Explore recruiting respiratory tract diseases clinical trials.

Recruiting respiratory tract diseases studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Respiratory Tract Diseases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Germany, Romania, Greece, Norway, Netherlands, Poland +4 more

Phase II and Phase III (Integrated) EU CTIS Study details

A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of mucus plugging and other lung imaging parameters in patients with chronic obstructive pulmonary disease (AEOLUS)

Netherlands, Hungary, France, Germany, Austria, Spain +4 more

Therapeutic use (Phase IV) EU CTIS Study details

Adoptive TIL therapy in combination with chemoimmunotherapy in advanced NSCLC patients

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A randomized, double blind, placebo controlled, Proof of Concept (PoC) study to assess the efficacy, safety and tolerability of itepekimab in participants with inadequately controlled chronic rhinosinusitis without nasal polyps

Portugal, Poland, Italy, Romania, Spain, France +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Denmark, Sweden, Poland, Estonia, Portugal, Latvia +7 more

Phase II and Phase III (Integrated) EU CTIS Study details

A randomized Phase 2, double-blind, placebo-controlled, parallel-group, 2-arm study to assess the efficacy, safety, and tolerability of subcutaneous lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP)

Bulgaria, Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Respiratory Tract Diseases trials by city

Respiratory Tract Diseases in Toronto Respiratory Tract Diseases in Vancouver Respiratory Tract Diseases in Montreal Respiratory Tract Diseases in Calgary Respiratory Tract Diseases in Edmonton Respiratory Tract Diseases in Ottawa Respiratory Tract Diseases in Winnipeg Respiratory Tract Diseases in Quebec City Respiratory Tract Diseases in Hamilton Respiratory Tract Diseases in Kitchener Respiratory Tract Diseases in London Respiratory Tract Diseases in Halifax Respiratory Tract Diseases in New York Respiratory Tract Diseases in Los Angeles Respiratory Tract Diseases in Chicago Respiratory Tract Diseases in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease